Brind.

MSD and Aurobindo Pharma signed a voluntary licensing agreement for generic alimatravir.

2 reports, 2 independent Updated Sep 1

No new developments lately

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

MSD and Aurobindo Pharma signed a voluntary licensing agreement for generic alimatravir.

Who's involved

What this event is mainly about

MSD Aurobindo Pharma

How it developed

Newest first. Tap a step to see who reported it.

Sep 1MSD to manufacture Alimatravir in Kenya, aiming for 60% local production by 2040.1 source
- standardmedia.co.ke
Jul 25MSD and Aurobindo Pharma agree on licensing for generic alimatravir.1 source
- equitybulls.com

Keep exploring

The entities involved

MSD
company in Rome, Italy
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
Aurobindo Pharma
an Indian pharmaceutical company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 1standardmedia.co.ke
Jul 25equitybulls.comAurobindo Pharma signs non-exclusive voluntary license agreement with MSD